Effect of BioStrength Training on Muscle Strength and Satisfaction in Adults Aged 30-65

NCT06727695 | Recruiting

• 1 other identifier: Bio-RCT-2024-01
• Study Type: interventional
• Target: 42
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to evaluate the effectiveness of Technogyms BioStrength equipment compared to traditional strength training equipment over a 12-week intervention period. The study will determine whether BioStrength machines produce more effective results in terms of muscle strength and body composition. Participants will be allocated to either the BioStrength group or the traditional training group using a minimisation technique to balance important prognostic factors such as handgrip strength, age and gender between the groups. Key measurements include maximum strength tests (10RM) for leg press and chest press, handgrip strength using a dynamometer, and body composition using bioimpedance analysis. Circumference measurements will also be taken. The study will assess whether BioStrength equipment provides superior results in muscle strength, body composition and training efficiency compared to conventional gym equipment.

Conditions

Muscle Strength; Body Composition; Physical Fitness

Keywords

Strength training; Muscle strength; Body composition; Customer satisfaction; BioStrength; Technogym; Resistance training; Fitness equipment; Handgrip strength; Randomized controlled trial

Outcome Measures

Primary Outcomes (4)

• Change in Skeletal Muscle Mass

  Skeletal muscle mass will be measured using bioimpedance analysis (BIA) at baseline and after the 12-week intervention to evaluate changes in muscle mass.

  Baseline and Week 12

• Change in Body Fat Percentage

  Body fat percentage will be measured using bioimpedance analysis (BIA) at baseline and after the 12-week intervention to assess reductions in body fat.

  Baseline and Week 12

• Change in Handgrip Strength

  Handgrip strength will be measured using a Jamar dynamometer, with measurements taken at baseline and after the 12-week intervention.

  Baseline and Week 12

• Change in Maximal Strength (10-RM Test)

  Maximal strength will be measured using the 10-RM (Repetition Maximum) test for the leg press and chest press exercises at baseline and after the 12-week intervention.

  Baseline and Week 12

Secondary Outcomes (2)

• Customer Satisfaction (CSAT Questionnaire)

  Week 2 and Week 12

• Change in Circumference Measurements (Arm, Leg, and Waist)

  Baseline and Week 12

Study Arms (2)

Control Group (No BioStrength Training)

ACTIVE COMPARATOR

Participants in the Active Comparator group will undergo a conventional strength training program using standard gym machines. Training sessions will occur 3 times per week for 12 weeks. The goal is to compare the outcomes of BioStrength training with traditional strength training.

Device: Conventional training

BioStrength training

EXPERIMENTAL

Participants in the Intervention Group will undergo BioStrength training using Technogym equipment. The intervention will last for 12 weeks, with sessions conducted 3 times per week

Device: BioStrength Intervention

Interventions

BioStrength Intervention DEVICE

Participants in the Intervention Group will undergo BioStrength training using Technogym equipment. The intervention will last for 12 weeks, with sessions conducted 3 times per week

BioStrength training

Conventional training DEVICE

Participants in the Active Comparator group will undergo a conventional strength training program using standard gym machines. Training sessions will occur 3 times per week for 12 weeks. The goal is to compare the outcomes of BioStrength training with traditional strength training.

Control Group (No BioStrength Training)

Eligibility Criteria

• Age: 30 Years - 65 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Age between 30 and 65 years
• Healthy individuals without significant medical conditions
• Less than 6 months of prior strength training experience
• Willing and able to participate in a 12-week training program
• Capable of performing strength training exercises such as leg press and chest press
• Able to provide written informed consent

You may not qualify if:

• History of coronary heart disease
• History of stroke
• Need for changes in antihypertensive treatment within 3 months prior to study start
• Arthritis
• Pregnancy or less than three months postpartum
• Pain and movement restrictions
• Use of medications that affect muscle strength or performance (e.g., anabolic steroids, beta-2 agonists, glucocorticoids, statins, benzodiazepines, ACE inhibitors, angiotensin-II receptor blockers, diuretics)
• Any medical condition preventing participation in planned endurance and strength training

Sponsors & Collaborators

• University of Graz: lead

Study Sites (1)

CF Leibnitz

Leibnitz, Styria, Styria, 8430, Austria

RECRUITING

MeSH Terms

Conditions

Consumer Behavior

Condition Hierarchy (Ancestors)

Behavior

Study Officials

• Martin Atia

  University of Graz

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Martin Atia

CONTACT

+436642524153; m.atia@edu.uni-graz.at

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 30, 2024
• First Posted: December 11, 2024
• Study Start: October 8, 2024
• Primary Completion: October 1, 2025
• Study Completion: October 1, 2025
• Last Updated: December 11, 2024

Record last verified: 2024-10

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL
• Time Frame: Available upon publication for one year

Locations

AU (1)